Mereo BioPharma Group plc (MREO) NASDAQ

0.66

+0.0927(+16.34%)

Updated at January 13 04:00PM

Currency In USD

Valuation

Market Cap517.74M
Enterprise Value454.36M
P/E Ratio-2.54
PEG Ratio-0.17
Price/Sales Ratio210.76
Price/Book Ratio2.27
Enterprise/Revenue114.16
Enterprise/EBITDA-1.31

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-83.02
Operating Margin-93.7

Management Effectiveness

Return On Assets-0.77
Return On Equity-0.75

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA-40.8M
Net Income-43.25M
Diluted EPS-0.29

Balance Sheet

Total Cash48.7M
Total Cash/Share0.3
Total Debt397,000
Total Debt/Equity0.01
Current Ratio8.71
Book Value Per Share0.29

Price History

52-Week Change-80.24
52-Week High3.26
52-Week Low0.2
Moving Average 50 Days1.65
Moving Average 200 Days2

Statistics

Average Volume12.2M
Shares Outstanding159.67M
% Held by Institutions62.69

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A